Systemic Therapy for SCLC: ASCO-OH (CCO) Guid...

Dr. Mary-Ellen Taplin joins the podcast to discuss the latest changes to the living guideline on metastatic castration-resistant prostate cancer (mCRPC). She reviews new treatment options for patients treated with ADT alone, ADT and an ARPI, ADT and docetaxel, and ADT, an ARPI, a ...  Show more

Dr. Lisa Hicks and Dr. Joseph Mikhael discuss the updated guideline from ASCO and Ontario Health (Cancer Care Ontario) on the treatment of multiple myeloma. They cover recommendations for therapeutic options across smoldering multiple myeloma, transplant eligible multiple myeloma ...  Show more

Doctors Vamsi Velcheti, Sandip Patel, and Michael Zervos discuss recent updates on the management of early-stage non-small cell lung cancer (NSCLC), including the optimization of neoadjuvant and adjuvant treatment options for patients and the role of surgery in the era of targ ...

<span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">Doctors James Ferriss, Linda Duska, and Jayanthi Lea discuss the promise and the challenges of targeting the immune system with immune checkpoin ...

Carl June is the pioneer behind CAR T-cell therapy: a groundbreaking cancer treatment that supercharges part of a patient's own immune system to attack and kill tumors. In a talk about a breakthrough, he shares how three decades of research culminated in a therapy that's eradi ...

View the Show Notes Page for This Episode

<a href= "https://peterattiamd.com/subscri ...